Tuesday, October 25, 2011

Novartis Slashes 2000 Jobs to Cut Costs - Oct. 25, 2011

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Tuesday, October 25, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Assay Depot has created the world's largest network of public and private cloud-based Research Exchanges:

Life science researchers from 53 countries use our public Research Exchange to find, create and purchase research services and products and to communicate with 5000+ research vendors.

Pharmaceutical companies, universities and non-profit organizations use a private Research Exchange to manage and strengthen internal and external research partnerships.

Research vendors use public and private Research Exchanges to offer their services and products to the global research community.

Researchers - Use our free public marketplace at assaydepot.com.
Vendors - Get a free vendor account at http://backoffice.assaydepot.com/.
HeadHtml
•  Novartis AG (NVS) Slashes 2000 Jobs to Cut Costs More...
More Job Industry News
HeadHtml
•  Karo Bio AB Prepares Spin-off of Preclinical Development More...
More New Company News
HeadHtml
•   Chromatin, Inc. Closes $10 Million Financing Round, Adds Strategic Investors More...
More Finance News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data sets and are expanding the range of problems that can be addressed through sequencing...

Request Now!
HeadHtml
•   Eli Lilly and Company (LLY) Not Interested in Buying Parts of Abbott Laboratories (ABT) More...
•   California Stem Cell, Inc. Acquires Cancer Stem Cell Therapy Program More...
•   Pop Test Cortisol Acquires Chemotherapy Sensitizer Org34517 From Merck & Co., Inc. (MRK) More...
More Mergers and Acquisitions News
HeadHtml
•   Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol More...
•   FUJIFILM Diosynth Biotechnologies and ContraFect Corporation Announce Development and Manufacturing Collaboration for Novel Anti-Staph Biologic More...
•   Momenta Pharmaceuticals, Inc. (MNTA) Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms More...
•   ProBioGen AG and Inhibrx Sign License Deal on GlymaxX(R) ADCC Technology for Therapeutic Antibodies Development More...
•   Pfizer Inc. (PFE) Selects Adams & Knight to Solidify VIAGRA(R) Brand in Africa and Middle East Markets More...
More Alliances News

•   Sanofi (France) (SASY.PA) Taps David Meeker as New CEO of Genzyme Corporation (GENZ) More...
•   Presidio Pharmaceuticals, Inc. Announces the Appointment of H. Daniel Perez, M.D. as President and Chief Executive Officer More...
•   Dr. Gengchen Han Returns to Origin Agritech Limited (SEED) as the CEO and President More...
•   Exelixis, Inc. (EXEL) Appoints Executive Vice President and Chief Commercial Officer More...
•   Vanda Pharmaceuticals, Inc. (VNDA) Appoints Chief Commercial Officer More...
More Personnel News
Tower: Facebook
HeadHtml
•   Anika Therapeutics (ANIK) Announces Date of Third-Quarter 2011 Financial Results Conference Call More...
•   Amgen (AMGN)'s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40 More...
•   Anthera Pharmaceuticals, Inc. (ANTH) Announces Third Quarter 2011 Financial Report and Conference Call More...
•   Cell Therapeutics, Inc. (CTIC) (CTI) Reports Third Quarter Financial Results and Milestones More...
•   Dr. Reddy's Laboratories Ltd. (RDY)'s Q2 FY12 Financial Results More...
More Earnings Report News
HeadHtml
•   Amgen (AMGN) to Pay $780 Million to Resolve Kickback Allegations More...
More Legal News
HeadHtml
•   Rainbow BioSciences, LLC Eyes Houston for New Biotech Division Headquarters More...
More Construction News
 
Real Estate



Exceptional Bioscience Facility
25 Crestridge Drive
Suwanee, Georgia U.S.A.

• 99,822 SF Bioscience Facility
• State-of-the-Art Building Systems, Fixtures and Equipment
• Constructed in 2000

More Real Estate Listings
Feature

Hot Company

Nektar Therapeutics
490 Discovery Drive
Huntsville, Alabama 35806 U.S.A.
Phone: 256-533-4201 Fax: 256-533-4805

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its proprietary polymer conjugation technology platform. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas.

More Company Profiles
Events

Acceleration 2011: Nutter Early Stage Life Sciences Conference
Thursday, November 17, 2011
Nutter Conference Center, Seaport West 155 Seaport Boulevard, 5th Floor
Boston, Massachusetts

This free event is by invitation only. To request an invitation, please visit: www.acceleration.nutter.com/2011.

An outstanding line-up of speakers is being assembled for this conference including representatives of Atlas Venture, GlaxoSmithKline (GSK), Novartis, Smith and Nephew, Longwood Founders Fund, and Pfizer.

Two panel discussions will examine issues and trends in early-stage development among life science companies.

Panel I will seek to answer the question "How Lean is Too Lean?" and will consider some of the pitfalls and challenges faced by development stage life science companies as they execute on a lean business model from raw technology through the clinical and operational phases of development and finally to commercial launch.

Panel II asks "Are Big Pharma and Big Device the New Development Accelerators?" and will examine how large companies are deploying new external investment and development models to optimize their "buy" and "build" pipelines. The program will be followed by cocktails, hors d'oeuvres and networking

To request an invitation, please visit www.acceleration.nutter.com/2011.
 
Top Jobs
Biotech Beach (San Diego, California)

Volcano Corporation
Peripheral Market Development Manager
Responsible for expanding IVUS applications in the peripheral arterial disease market. Creating and optimizing opportunities through strategic planning and managing execution of plans. This is a "downstream" marketing role.

Pharm Country (Conshohocken, Pennsylvania)

Agility Centralized Research Services (ACRS), Inc., a CardioNet Company
Research Sales Executive
Agility Centralized Research Services (ACRS), Inc., a CardioNet Company, is seeking a Research Sales Executive to assume direct control over the sales effort, marketing, contracting and delivery of new products and services from ACRS, Inc.

BioCaptial (Gaithersburg, Maryland)

MedImmune, LLC
Director, RSV Marketing
The Director, RSV Marketing will report directly to the Vice President, Franchise Head, Pediatric Infectious Disease. He/she will be responsible for market strategy development in support of MedImmune's Synagis (palivizumab) brand. This position will have multi-faceted responsibility with numerous contact points and will require a diverse talented individual who excels in cross-functional marketing collaborations, both internal and external.

Biotech Bay (Menlo Park, California)

ForteBio, Inc.
Technical Sales Administrator
Report to VP of Sales to assist with worldwide sales process. A combination of technical and administrative skills will be needed. Duties of the role will include updating price lists, preparing customer quotations, entering sales orders, coordinating shipping requirements, reporting sales results, administering the Ecommerce site, and maintaining customer databases.

Southern Pharm (Jacksonville, Florida)

Astellas Pharma US
Hospital - Pharmaceutical Sales Representative
Ensure the achievement of sales goals in territory by promoting Astellas products and services to physicians and other medical personnel within assigned geography. Educate customers on the use, characteristics, advantages, indicated treatments and all other developments related to promoted products.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs

Biotech Bay Career Fair

BioCapital Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the mid-atlantic region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

BioCapital Beach Career Fair, Bethesda, MD November 1, 2011
Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


No comments: